A rating of 68 puts Kymera Therapeutics Inc (KYMR) near the top of the Biotechnology industry according to InvestorsObserver. Kymera Therapeutics Inc's score of 68 means it scores higher than 68% of stocks in the industry. Kymera Therapeutics Inc also received an overall rating of 61, putting it above 61% of all stocks. Biotechnology is ranked 18 out of the 148 industries.
KYMR has an Overall Score of 61. Find out what this means to you and get the rest of the rankings on KYMR!